Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997139 · ClinicalTrials.gov registry record · NA
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
NCT00997139 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 216 participants.
The verdict
NCT00997139, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
Study Summary
Staphylococcus aureus, a bacteria that lives commonly in the anterior nostrils, is seen in about 30% of healthcare workers. Applying mupirocin ointment, a prescription, to the nostrils twice daily for 5 days is the current standard of care for treatment to clear this bacteria. This research study is designed to determine the rate of clearance of this bacteria in healthcare workers who are carriers when using triple antibiotic ointment instead of mupirocin ointment.
Interventions
- DRUG Neosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00997139
The ClinicalTrials.gov registry entry for NCT00997139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg) is the first listed.
NCT00997139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00997139 about?
NCT00997139 is a clinical study titled "Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment". Staphylococcus aureus, a bacteria that lives commonly in the anterior nostrils, is seen in about 30% of healthcare workers. Applying mupirocin ointment, a prescription, to the nostrils twice daily for 5 days is the current standard of care for treatment to clear this bacteria. This research study is...
What is the current status of trial NCT00997139?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2009-09. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00997139?
The interventions under investigation include: Neosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg) (DRUG).
Who is sponsoring clinical trial NCT00997139?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.